page 1
page 2
page 3
page 4
page 5
page 6
page 7
page 8
page 9
page 10
page 11
page 12
page 13
page 14
page 15
page 16
page 17
page 18
page 19
page 20
page 21
page 22
page 23
page 24
page 25
page 26
page 27
page 28
page 29
page 30
page 31
page 32
page 33
page 34
page 35
page 36
page 37
page 38
page 39
page 40
page 41
page 42
page 43
page 44
page 45
page 46
page 47
page 48
page 49
page 50
page 51
page 52
page 53
page 54
page 55
page 56
page 57
page 58
page 59
page 60
page 61
page 62
page 63
page 64
page 65
page 66
page 67
page 68
page 69
page 70
page 71
page 72
page 73
page 74
page 75
page 76
page 77
page 78
page 79

17Spire Healthcare's customer proposition and strategyWith three years of strong growth across all areas of the business, our strategy has proven to be successful.We continue to expand the volume and range of services offered by our hospitals, focusing on working collaboratively with consultants, with the goal of delivering the highest clinical standards and premium patient services, supported by investment in our staff and facilities. Consultants are our most important stakeholders. Our aim is to provide them with the best service in every region where there is a Spire hospital and, in so doing, to deliver the best private healthcare experience for patients.Growth and innovationOur focus on investing in innovative treatments and services in areas of high demand continues to stimulate revenue growth. Pathology is a particularly strong area, delivering a solid return on our two years of capital investment in advanced facilities and equipment to develop a high-quality, efficient network of laboratories that offer a range of electronic reporting systems. This includes a web-based results service that reduces turnaround times and enhances customer service. In 2010 we secured external contracts with a wide range of third parties and this success has continued into 2011, with a number of large and smaller opportunities in development. 26.4%20102008200921.6%24.8%Key performance indicatorsImprovements in EBITDAR (pre-exceptional items)2008£127.4m2010£169.8m2009£153.6mIncreasing EBITDAR margin (pre-exceptional items)

18Spire Healthcare Annual Review 2010Business review continuedThe restructure has resulted in consultant satisfaction increasing, the hospital taking on more complex work and there is now a waiting list to join our team.""